KOSDAQ · Healthcare · ₩152B
₩11,320-5.43%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 13.5% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“신약 개발은 앞으로 가지만 돈 버는 힘은 더 키워야 해요.”
In the company's words · 2026 2분기 filing